Literature DB >> 35608708

Cost of postoperative complications of lower anterior resection for rectal cancer: a nationwide registry study of 15,187 patients.

Hiraku Kumamaru1, Yoshihiro Kakeji2, Kiyohide Fushimi3, Koichi Benjamin Ishikawa4, Hiroyuki Yamamoto5, Hideki Hashimoto6, Minoru Ono7, Tadashi Iwanaka5, Shigeru Marubashi2, Mitsukazu Gotoh8, Yasuyuki Seto8, Yuko Kitagawa8, Hiroaki Miyata5.   

Abstract

PURPOSE: To assess the increase in hospital costs associated with postoperative complications after lower anterior resection (LAR) for rectal cancer.
METHODS: The subjects of this retrospective analysis were patients who underwent elective LAR surgery between April, 2015 and March, 2017, collected from a Japanese nationwide gastroenterological surgery registry linked to hospital-based claims data. We evaluated total and category-specific hospitalization costs based on the level of postoperative complications categorized using the Clavien-Dindo (CD) classification. We assessed the relative increase in hospital costs, adjusting for preoperative factors and hospital case volume.
RESULTS: We identified 15,187 patients (mean age 66.8) treated at 884 hospitals. Overall, 71.8% had no recorded complications, whereas 7.6%, 10.8%, 9.0%, 0.6%, and 0.2% had postoperative complications of CD grades I-V, respectively. The median (25th-75th percentiles) hospital costs were $17.3 K (16.1-19.3) for the no-complications group, and $19.1 K (17.3-22.2), $21.0 K (18.5-25.0), $27.4 K (22.4-33.9), $41.8 K (291-618), and $22.7 K (183-421) for the CD grades I-V complication groups, respectively. The multivariable model identified that complications of CD grades I-V were associated with 11%, 21%, 61%, 142%, and 70% increases in in-hospital costs compared with no complications.
CONCLUSIONS: Postoperative complications and their severity are strongly associated with increased hospital costs and health-care resource utilization. Implementing strategies to prevent postoperative complications will improve patients' clinical outcomes and reduce hospital care costs substantially.
© 2022. The Author(s).

Entities:  

Keywords:  Clavien–Dindo classification; Cost; Lower anterior resection; Postoperative complications

Year:  2022        PMID: 35608708     DOI: 10.1007/s00595-022-02523-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  Initial verification of data from a clinical database of gastroenterological surgery in Japan.

Authors:  Shingo Kanaji; Arata Takahashi; Hiroaki Miyata; Shigeru Marubashi; Yoshihiro Kakeji; Hiroyuki Konno; Mitsukazu Gotoh; Yasuyuki Seto
Journal:  Surg Today       Date:  2018-11-07       Impact factor: 2.549

2.  Medicare's use of cost-effectiveness analysis for prevention (but not for treatment).

Authors:  James D Chambers; Michael J Cangelosi; Peter J Neumann
Journal:  Health Policy       Date:  2014-11-22       Impact factor: 2.980

3.  Consequence of reimbursement policy alteration for urgent PCI in Japan.

Authors:  Nobuhiro Ikemura; Mitsuaki Sawano; Ikuko Ueda; Keiichi Fukuda; Shun Kohsaka
Journal:  Lancet       Date:  2018-06-01       Impact factor: 79.321

4.  Supplier-induced demand for newborn treatment: evidence from Japan.

Authors:  Hitoshi Shigeoka; Kiyohide Fushimi
Journal:  J Health Econ       Date:  2014-03-26       Impact factor: 3.883

Review 5.  Challenges and prospects of a clinical database linked to the board certification system.

Authors:  Hiroaki Miyata; Mitsukazu Gotoh; Hideki Hashimoto; Noboru Motomura; Arata Murakami; Ai Tomotaki; Norimichi Hirahara; Minoru Ono; Clifford Ko; Tadashi Iwanaka
Journal:  Surg Today       Date:  2014-05-23       Impact factor: 2.549

6.  Comparison of National Operative Mortality in Gastroenterological Surgery Using Web-based Prospective Data Entry Systems.

Authors:  Takayuki Anazawa; Jennifer L Paruch; Hiroaki Miyata; Mitsukazu Gotoh; Clifford Y Ko; Mark E Cohen; Norimichi Hirahara; Lynn Zhou; Hiroyuki Konno; Go Wakabayashi; Kenichi Sugihara; Masaki Mori
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.